Literature DB >> 19352687

[Scleroderma and fibrosing diseases].

U A Walker1, P Knöss, M Jakobs, V Krenn.   

Abstract

Fibroblasts and myofibroblasts play an important role in the pathogenesis of systemic sclerosis, fibromatoses, arthrofibrosis, and Ormond's disease. These conditions are characterized by an excessive fibroblast proliferation and partly accompanied by inflammation. Scleroderma is either localized or systemic, and features additional vasculopathy. Scleroderma-like skin lesions can be found in graft-versus-host disease following allogeneic hematopoietic stem cell transplantation, complicated malignoma or can represent an adverse drug reaction. The fibromatoses are found in superficial, or as semi-malignant desmoids in deep body compartments. Ormond's disease is a chronic periaortitis of unknown origin which extends into the retroperitoneal space. The diagnostic relevance of a histopathological diagnosis of fibrosing diseases varies and ranges from a disease-supporting to a disease-defining value.

Entities:  

Mesh:

Year:  2009        PMID: 19352687     DOI: 10.1007/s00393-008-0401-7

Source DB:  PubMed          Journal:  Z Rheumatol        ISSN: 0340-1855            Impact factor:   1.372


  23 in total

1.  Arthrofibrosis is the result of a T cell mediated immune response.

Authors:  U Bosch; J Zeichen; M Skutek; L Haeder; M van Griensven
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2001-09       Impact factor: 4.342

Review 2.  Scleroderma renal crisis.

Authors:  Virginia D Steen
Journal:  Rheum Dis Clin North Am       Date:  2003-05       Impact factor: 2.670

Review 3.  [Therapy of arthrofibrosis after total knee arthroplasty].

Authors:  H Gollwitzer; R Burgkart; P Diehl; R Gradinger; V Bühren
Journal:  Orthopade       Date:  2006-02       Impact factor: 1.087

4.  Pseudoscleroderma associated with cancer.

Authors:  K Kikuchi; T Hoashi; N Yazawa; K Tamaki
Journal:  Clin Exp Dermatol       Date:  2006-05       Impact factor: 3.470

Review 5.  Primary myocardial involvement in systemic sclerosis.

Authors:  A Kahan; Y Allanore
Journal:  Rheumatology (Oxford)       Date:  2006-10       Impact factor: 7.580

Review 6.  Scleredema adultorum of Buschke: a case report and review of the literature.

Authors:  William H Beers; Akgun Ince; Terry L Moore
Journal:  Semin Arthritis Rheum       Date:  2006-06       Impact factor: 5.532

Review 7.  Updated classification of papular mucinosis, lichen myxedematosus, and scleromyxedema.

Authors:  F Rongioletti; A Rebora
Journal:  J Am Acad Dermatol       Date:  2001-02       Impact factor: 11.527

8.  Endothelial injury mediated by cytotoxic T lymphocytes and loss of microvessels in chronic graft versus host disease.

Authors:  Barbara C Biedermann; Silvia Sahner; Michael Gregor; Dimitrios A Tsakiris; Christina Jeanneret; Jordan S Pober; Alois Gratwohl
Journal:  Lancet       Date:  2002-06-15       Impact factor: 79.321

Review 9.  The pathology of scleroderma vascular disease.

Authors:  Jo Nadine Fleming; Stephen Mark Schwartz
Journal:  Rheum Dis Clin North Am       Date:  2008-02       Impact factor: 2.670

Review 10.  Gastrointestinal manifestations of systemic sclerosis.

Authors:  Robyn Domsic; Kenneth Fasanella; Klaus Bielefeldt
Journal:  Dig Dis Sci       Date:  2007-10-13       Impact factor: 3.199

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.